# Sarepta Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/sarepta-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 9 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-14T04:46:05.447223+00:00 |
| Last reviewed | 2026-11-14T04:46:05.447223+00:00 |

## Identity

- Legal name: Sarepta Therapeutics, Inc.
- Display name: Sarepta Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-14T04:46:05.447223+00:00 |
| Completeness | 0.318 |
| Record Quality | 0.812 |
| Directors | 0 |
| Committees | 0 |
| Governance events | 5 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | NOT_REVIEWED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Executive leadership

- Cristin L. Rothfuss: Executive Vice President, General Counsel [GC]. Status: current. claim_id=alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:5
- Douglas S. Ingram: Chief Executive Officer; Class I Director [CEO]. Status: current. claim_id=alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:6
- Ian M. Estepan: President, Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:7
- Louise Rodino-Klapac, Ph.D.: President, Research and Development and Technical Operations [PRESIDENT]. Status: current. claim_id=alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:8
- Richard P. Wong: Executive Vice President, Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:9

## Governance events

- GC_ROLE_RECORDED: Cristin L. Rothfuss executive of Sarepta Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-11-14T04:46:05.447223+00:00. event_id=alpha:event:transition:1eie8ravp3fco
- CEO_ROLE_RECORDED: Douglas S. Ingram executive of Sarepta Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-11-14T04:46:05.447223+00:00. event_id=alpha:event:transition:17pey6u1w070to
- EXECUTIVE_APPOINTED: Ian M. Estepan executive of Sarepta Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-11-14T04:46:05.447223+00:00. event_id=alpha:event:transition:igem6e1mhnkca
- EXECUTIVE_APPOINTED: Louise Rodino-Klapac, Ph.D. executive of Sarepta Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-11-14T04:46:05.447223+00:00. event_id=alpha:event:transition:ghkd1bgov4af
- CFO_ROLE_RECORDED: Richard P. Wong executive of Sarepta Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-11-14T04:46:05.447223+00:00. event_id=alpha:event:transition:7oxr59ojxtl9

## Scoped resources

- `alpha://company/sarepta-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record
- `alpha://company/sarepta-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=identity
- `alpha://company/sarepta-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/sarepta-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=board
- `alpha://company/sarepta-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=committees
- `alpha://company/sarepta-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=leadership
- `alpha://company/sarepta-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=ownership
- `alpha://company/sarepta-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=financials
- `alpha://company/sarepta-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/sarepta-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=compensation
- `alpha://company/sarepta-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=governance
- `alpha://company/sarepta-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/sarepta-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=audit
- `alpha://company/sarepta-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=legal
- `alpha://company/sarepta-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=risk
- `alpha://company/sarepta-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=cyber
- `alpha://company/sarepta-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/sarepta-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=agents
- `alpha://company/sarepta-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/sarepta-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=events
- `alpha://company/sarepta-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=relationships
- `alpha://company/sarepta-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=assessments
- `alpha://company/sarepta-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Cristin L. Rothfuss: Executive Vice President, General Counsel. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:5. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bbf263f7234bd3ff5a9e4f07b78c0d0dcb9511378055415fc6a0385ff542ba30.
- Douglas S. Ingram: Chief Executive Officer; Class I Director. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:6. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cd9fb0cd7bd9ff7876e4a18e9e0a3a006d52fa15e0ae9577ef6c893eb9d32ddf.
- Ian M. Estepan: President, Chief Operating Officer. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:7. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4275e5baf7bb2e8b35d1c19e28be0c3e0014c7233ad5ee2b11c469785723076a.
- Louise Rodino-Klapac, Ph.D.: President, Research and Development and Technical Operations. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:8. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:251bc1dd9a8d88945182396512c99234329c6dd4324cb32546f17ef24a57f951.
- Richard P. Wong: Executive Vice President, Chief Financial Officer. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:leadership_role:9. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:290ecb3afbe5dd9cef7eed42c71e7430f5a7bd9b4c4ebdc0c0b26e9f3424b020.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- NOT_ASSERTED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Sarepta Therapeutics, Inc.. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cb6090487f961685d7543516dd476dfd1e7be152220ea6dcad0915ab296e794a.

## Entity Status

- Public listing published. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cb6090487f961685d7543516dd476dfd1e7be152220ea6dcad0915ab296e794a.

## Published Fact

- US. Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cb6090487f961685d7543516dd476dfd1e7be152220ea6dcad0915ab296e794a.

## Security Listing

- SRPT (NASDAQ). Claim: alpha:claim:company:3bbaa2bb-8907-4a52-acba-a1fa0f0d0ed2:security_listing:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cb6090487f961685d7543516dd476dfd1e7be152220ea6dcad0915ab296e794a.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | NOT_ASSERTED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:cb6090487f961685d7543516dd476dfd1e7be152220ea6dcad0915ab296e794a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sarepta-therapeutics-inc).
- alpha:projection-evidence:document:bbf263f7234bd3ff5a9e4f07b78c0d0dcb9511378055415fc6a0385ff542ba30: [SRPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm).
- alpha:projection-evidence:document:cd9fb0cd7bd9ff7876e4a18e9e0a3a006d52fa15e0ae9577ef6c893eb9d32ddf: [SRPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm).
- alpha:projection-evidence:document:4275e5baf7bb2e8b35d1c19e28be0c3e0014c7233ad5ee2b11c469785723076a: [SRPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm).
- alpha:projection-evidence:document:251bc1dd9a8d88945182396512c99234329c6dd4324cb32546f17ef24a57f951: [SRPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm).
- alpha:projection-evidence:document:290ecb3afbe5dd9cef7eed42c71e7430f5a7bd9b4c4ebdc0c0b26e9f3424b020: [SRPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/sarepta-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/sarepta-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/sarepta-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/sarepta-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-15T03:01:25.983046+00:00; recorded 2026-11-15T03:01:25.983046+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.